As per the company's filing, the United Nations International Children's Emergency Fund (UNICEF) awarded the company to ...

Shares of Panacea Biotec rose 4.99% on Thursday to the day's high of Rs 456 after the company received a Letter of Award from ...

Panacea Biotec announced that it was awarded a contract from United Nations International Children's Emergency Fund (UNICEF) ...

Following a UNICEF order worth ₹127 crore, Panacea Biotec shares increased 5% to ₹456.25. The stock has seen substantial ...

Such a contract symbolizes Panacea Biotec's continued commitment toward global health by contributing its share of the fight ...

Shares of Panacea Biotec are now locked in an upper circuit of 5% at ₹454.90. With today's surge, the stock has rallied over ...

Panacea Biotec Inc. being a step-down subsidiary of the company. The investment made by PBPL in WOS is to facilitate the capex and working capital requirements of PB Inc. and is in furtherance of its ...

The share touched a 52-week high of Rs 489.00 and a 52-week low of Rs 112.70 on 12 December, 2024 and 04 June, 2024, respectively. Currently, the stock is trading 11.13 percent below its 52-week high ...

Panacea Biotec Limited has received a Letter of Award from UNICEF for supply of 115 million doses of its bivalent oral polio vaccine (bOPV) worth ~US$ 14.95 million (~Rs.127 Crore) in CY2025.

Indias leading research-based health management company with established research, manufacturing and marketing capabilities are collectively known as Panacea Biotec Limited (PBL), which was ...

Panacea Biotec stock opened with a gain of 5 percent to hit an intraday high of Rs 454.90 per share on the NSE. Later, it pared some of the gains to quote at Rs 445.05 apiece, up 2.72 percent at ...